From my understanding phase 4 is just monitoring patients taking the product once the product has been approved and is on the market.
Happy to be corrected
Overwhelming efficacy - the stats required, page-208
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.311M | 1.421M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14683 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.5¢ | 24549 | 4 |
View Market Depth
| Last trade - 15.59pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |